Sir Philip Cohen (born 22 July 1945) is a distinguished English biochemist known for his extensive contributions to the field of biochemistry, especially to the understanding of the role of reversible protein phosphorylation in cell regulation.
[7] Cohen's contributions to the field were recognized by the Royal Society, which appointed him as a Research Professor at the University of Dundee from October 1984 to September 2010.
[9] He reverted to his original position as Professor of Enzymology at the School of Life Sciences, University of Dundee, from April 2012 onwards.
His expertise also brought him to the international stage, serving as a Vallee Visiting Professor at Harvard Medical School since November 2013.
[10] Cohen played a pivotal role in forming the Division of Signal Transduction Therapy in July 1998, co-directoring it with Sir Peter Downes until June 2012 and continuing as its deputy director until 2022.
[12] Cohen was elected a Member of the European Molecular Biology Organisation in 1982 and subsequently became a Fellow of the Royal Societies of both London and Edinburgh in 1984.